Earlier syringe development may cut time-to-market, increase clinical trial appeal Ravensburg, Germany, April 9, 2014 / B3C newswire / – Vetter, a leading contract development and manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback